Molecular Characterization of Carbapenemase-Producing Enterobacterales
NCT ID: NCT07116356
Last Updated: 2025-08-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
100 participants
INTERVENTIONAL
2025-09-10
2026-02-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Carbapenem and Quinolone Resistance in Klebsiella Pneumoniae
NCT03767283
Clinical and Microbiological Outcomes of Infections Due to Carbapenem-Resistant Gram-Negative Bacteria
NCT01041716
A Post-Marketing Study to Assess the Efficacy and Safety of Intravenous Polymyxin B and Colistin Methanesulfonate in Patients With Carbapenem-Resistant Gram-Negative Bacterial Infection
NCT06966284
Antibacterial Effect of Zinc Oxide Nanoparticles on Acinetobacter Baumannii Isolated from Patients with Hospital Acquired Infections in Sohag University Hospitals, Egypt
NCT06628076
Different Dosing Strategies of Colistin in Multidrug-Resistant Gram-Negative Bacilli Infections
NCT06843668
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
SCREENING
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1 Patients with enterobacterials infections
Antibiotic administration
different samples were collected from patients admitted at oncology center at sohag
Molecular detection of antibiotic resistance
Molecular detection of carbapenem resistant genes:
* Extraction of nucleic acid from isolated organisms by boiling.
* Primers will be used for detection of carbaenem resistant genes
Group 2 patients with other bacterial infections
Antibiotic administration
different samples were collected from patients admitted at oncology center at sohag
Molecular detection of antibiotic resistance
Molecular detection of carbapenem resistant genes:
* Extraction of nucleic acid from isolated organisms by boiling.
* Primers will be used for detection of carbaenem resistant genes
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Antibiotic administration
different samples were collected from patients admitted at oncology center at sohag
Molecular detection of antibiotic resistance
Molecular detection of carbapenem resistant genes:
* Extraction of nucleic acid from isolated organisms by boiling.
* Primers will be used for detection of carbaenem resistant genes
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
4 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sohag University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Noha Saber Shafik
assistant professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sohag university, Faculty of medicine
Sohag, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Related Links
Access external resources that provide additional context or updates about the study.
Related Info
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Soh-Mmed-25-7-10PD
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.